Project Number 1R21AG050158-01 Agency/Funding Organization NIA Funding Year 2015 View Full Project Details for DOUBLE-BLOCKING ANTI-CROSSLINKING STRATEGY FOR AD DRUG DEVELOPMENT Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator RAN, CHONGZHAO Principal Investigator First Name CHONGZHAO Principal Investigator Last Name RAN Awardee Organization MASSACHUSETTS GENERAL HOSPITAL Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-13-049: Drug Discovery for Nervous System Disorders (R21) FY Overall Cost $259,147 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
